REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > O-glycoside > Glucosamine Or Derivative Glucosamine Or DerivativeGlucosamine Or Derivative patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.02/01/07 - 20070027110 - Double salts of (-)-hydroxycitric acid with an amine and a group ii a metal and a process for preparing the same This invention relates to novel double salt of (−)-hydroxycitric acid with an amine and zinc or a group II A metal. These compounds are stable and water soluble and are used as nutraceuticals, weight reducing agents and in beverages. The double salts have the following general formula (I) Wherein X ... 01/25/07 - 20070021381 - Method for increasing the activity of lysosomal enzymes Method for enhancing in a mammalian cell the activity of an enzyme associated with Gaucher Disease by administering a competitive inhibitor of glucocerebrosidase in an amount effective to enhance the activity of the enzyme. Preferred compounds for use in the method are imino sugars and related compounds. In particular, C8-12-alkyl ... 12/14/06 - 20060281708 - Fluorinated glucosamine analogs useful for modulating post-translational glyscosylations on cells The present invention provides compositions and methods for inhibiting cell migration, e.g., lymphocytes and inflammation. The invention also provides an improved process for preparing fluorinated N-acetylglucosamines. ... 12/14/06 - 20060281707 - Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals The present invention discloses a use of N-acetyl-D-glucosamine in the manufacture of a medicament for treating organ lesions caused by toxicants and drugs. A preparation comprising N-acetyl-D-glucosamine as main active component for treating organ lesions caused by toxicants and drugs exhibits merits of a directive action mechanism, significant therapeutical effects ... 08/24/06 - 20060189575 - Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels The present invention is in the field of cholesterol and triglyceride-lowering methods and compositions. In particular, the present invention relates to the use of sphingolipids, more preferably phytosphingosine, sphingosine, sphinganine, ceramide, cerebroside and/or sphingomyelin for lowering the cholesterol and triglyceride levels in a subject and to the use of sphingolipids ... 08/10/06 - 20060178344 - Glucosamine and n-acetylglucosamine and methods of making the same fungal biomass Glucosamine, N-acetylglucosamine and β-glucan compositions suitable for human or animal consumption or use are disclosed. The glucosamine, N-acetylglucosamine and β-glucan compositions are derived from fungal biomass containing chitin. Various methods of producing glucosamine, N-Acetylglucosamine and β-glucan compositions are also disclosed. ... 07/06/06 - 20060148758 - Method for blood glucose control in a mammal by n-acylated glucosamines wherein R is an alkyl radical of the general formula CnH2n+1 wherein n is selected from 2-12; and pharmaceutically-acceptable salts, esters and glucosides thereof. ... 06/29/06 - 20060142244 - Geranyl compounds in which R1, R2, R3, m, n and R4 have the significations as given in the specification. ... 06/29/06 - 20060142243 - Use of n-acetyl-d-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention The present invention discloses a use of N-acetyl-D-glucosamine in the manufacture of a medicament for treatment of urogenital tract infection. N-acetyl-D-glucosamine exhibits a function of suppressing the transplantation of exotic microorganisms and promoting the repair of topical skin tissue, and the formulation comprising it as a main active component is ... 06/15/06 - 20060128659 - Sulfotransferase inhibitors wherein R1, R2 and R5 each independently represents SO3− or H, and at least one of them represents SO3−; R3 represents H, acetyl or SO3−; R4 represents H, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group, a substituted or unsubstituted ... 03/16/06 - 20060058263 - Heat pasturized liquids containing glucosamine The disclosure provides methods of making heat-pasteurized liquids, such as beverages, that contain glucosamine, wherein glucosamine is present in the beverage during the pasteurization process. The disclosure also provides liquids, such as beverages, made by these methods, as well as methods of using the glucosamine supplemented liquids, for example to ... 03/02/06 - 20060046976 - Method for increasing the bone mineral density and bone micro-architecture or connectivity of a mammal using n-acylated glucosamines wherein R is an alkyl radical of the general formula CnH2n+1 and n is selected from 2-12; or pharmaceutically-acceptable salts, esters and glucosides thereof; or pharmaceutically-acceptable compositions thereof. ... 03/02/06 - 20060046975 - Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis A method for preparing a medical solution, comprising the steps of a) providing a solution comprising one or more acetylated or deacetylated amino sugar/sugars in at least one compartment of a container in a concentration from 15% by weight to 40% by weight, with the basis of the solution in ... 01/05/06 - 20060003965 - N-acetyl-d-glucosamine (nag) supplemented food products and beverages Food products and beverages which include N-acetyl-D-glucosamine (NAG) are provided, as are methods of their use and preparation. Embodiments of the supplemented food products and beverages are heated to high temperatures, such as those used in pasteurization, without significant adverse effects on taste, color, odor and/or texture. ... 11/10/05 - 20050250739 - Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use R6 and R6′ are selected from the group consisting of hydrogen, hydroxyl, alkoxyl, carboxyl, alkoxylcarbonyl, aminocarbonyl, alkylamino-carbonyl and dialylamino-carbonyl, with the proviso that Ring 1 is capable of binding to any of: a dopaminergic receptor selected from the group consisting of a D1 receptor and a D5 receptor; a DAT ... 10/27/05 - 20050239749 - External preparation wherein Y, n and R6 are also defined. ... 08/04/05 - 20050171058 - Method for preparing a glucosamine compounds and compound thus obtained Method for preparing a compound comprising protonated glucosamine and Cl−, Na+ and SO42− ions, in which (a) glucosamine hydrochloride and a stoichiometric excess of sodium sulphate are placed in water, (b) the mixture obtained from the preceding step (a) is heated, (c) the mixture is cooled, and (d) the solid ... 07/07/05 - 20050148546 - Deacetylation of n-acetylglucosamine The invention provides methods of deacetylating N-acetylglucosamine by solid acid hydrolysis on a cation exchange resin. These methods advantageously reduce the amount of acid used and the need for acid recycle facilities. The isolated glucosamine salt produced is very clean, reducing or eliminating the need for further purification steps to ... 07/07/05 - 20050148545 - Glucosamine organic acid adducts The invention pertains to compositions containing glucosamine and organic acids, methods of making such compositions and methods of using such compositions. ... 06/16/05 - 20050130935 - Combination of a beta-2-adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders The invention relates to combinations of an aminosugar and a beta-2-adrenoceptor agonist, such as salbutamol, for the treatment of diseases associated with hypersensivity and inflamation, in particular hypersensivity skin diseases. The aminosugar is preferably a monosaccharide derivative. ... 06/02/05 - 20050119224 - Use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for adjuvant treatment of perianal disease The present invention has disclosed a use of N-acetyl-D-glucosamine in the manufacture of a medicine for auxiliary treatment of the peri-anal disease. Through stabilizing celluar lysosome membrance, the degree and scope of the injure extended by the release of various enzymes in the cellular lysosome are decreased; improving the healing ... ### FreshPatents.com Support |